| A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia NJ Shah, AJ Najibi, TY Shih, AS Mao, A Sharda, DT Scadden, DJ Mooney Nature biomedical engineering 4 (1), 40-51, 2020 | 37 | 2020 |
| CD4 T-cells regulate angiogenesis and myogenesis BJ Kwee, E Budina, AJ Najibi, DJ Mooney Biomaterials 178, 109-121, 2018 | 29 | 2018 |
| Acetalated dextran nanoparticles loaded into an injectable alginate cryogel for combined chemotherapy and cancer vaccination T Bauleth‐Ramos, TY Shih, MA Shahbazi, AJ Najibi, AS Mao, D Liu, ... Advanced Functional Materials 29 (35), 1903686, 2019 | 25 | 2019 |
| Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors H Wang, AJ Najibi, MC Sobral, BR Seo, JY Lee, D Wu, AW Li, ... Nature communications 11 (1), 1-14, 2020 | 24 | 2020 |
| Treating ischemia via recruitment of antigen-specific T cells BJ Kwee, BR Seo, AJ Najibi, AW Li, TY Shih, D White, DJ Mooney Science advances 5 (7), eaav6313, 2019 | 16 | 2019 |
| Cell and tissue engineering in lymph nodes for cancer immunotherapy AJ Najibi, DJ Mooney Advanced Drug Delivery Reviews, 2020 | 11 | 2020 |
| Ultrasound-triggered release reveals optimal timing of CpG-ODN delivery from a cryogel cancer vaccine TY Shih, AJ Najibi, AL Bartlett, AW Li, DJ Mooney Biomaterials, 121240, 2021 | | 2021 |
| Abstract PO085: Cryogel-based cancer vaccine to treat acute myeloid leukemia AJ Najibi, NJ Shah, TY Shih, AS Mao, A Sharda, DT Scadden, DJ Mooney Cancer Immunology Research 9 (2 Supplement), PO085-PO085, 2021 | | 2021 |
| Abstract B045: Antigen-free cancer vaccine to treat poorly immunogenic tumors MC Sobral, H Wang, AJ Najibi, A Li, CS Verbeke, DJ Mooney Cancer Immunology Research 7 (2 Supplement), B045-B045, 2019 | | 2019 |
David MooneyHarvard, MIT, MichiganEmail yang diverifikasi di seas.harvard.edu
